Market Overview:
The global immobilized trypsin market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for immobilized trypsin from academic & research institutes and pharmaceutical companies. Additionally, the growing awareness about proteomics is also propelling the growth of this market. However, factors such as high cost and limited availability are restraining its growth. On the basis of type, 2 ml segment is expected to hold a major share in the global immobilized trypsin market during the forecast period owing to its low price and easy availability as compared to 4 ml and other types of immobilized trypsins. On account of rising demand for proteomics research, academic & research institutes are anticipated to be one of key end-users for immobilized trypsin during 2018-2030 period.
Product Definition:
An immobilized enzyme is one that has been adsorbed to a surface or covalently bonded to a support.Immobilized trypsin is used in many biochemical assays, including the determination of protein concentration, the detection of peptides and proteins, and the sequencing of peptides.
2 ml:
The 2 ml usage is for the concentration of enzymes in a particular solution. It helps to measure the enzyme activity in a specific volume of solution. The growth factor is that it helps to determine if there are any impurities or other compounds present in the reaction mixture which may affect the results.
2 ml, also known as microlitre, is an international unit used for measuring small volumes such as Solutions and suspensions.
4 ml:
Immobilized trypsin is a serine protease inhibitor that works by preventing the conversion of amino acids into proteins. It is used to treat conditions such as rheumatoid arthritis, osteoporosis, and gouty arthritis. The medicine works by decreasing joint pain and inflammation.
Application Insights:
The academic and research institutes segment held the largest share of 60.0% in 2017. The pharmaceutical companies are expected to be the fastest-growing segment, registering a CAGR of XX% from 2018 to 2030 owing to rising product demand for protein crystallization and other biopharmaceutical processes at industrial scale.
Immobilized trypsin finds applications in various fields such as drug discovery & development, academic research institutes & centers, clinical trials and others such as food & beverage processing plants and textile industries among others where it is used for proteolysis or breakdown of proteins into smaller components under conditions that would not allow complete hydrolysis or degradation of the protein molecule leading to improved yield/ productivity with less expenditure on enzyme costs coupled with increased stability towards heat & pH (Enzymes).
Regional Analysis:
North America held the largest share of global immobilized trypsin market in 2017. The growth is attributed to the presence of a large number of pharmaceutical companies and academic & research institutes in this region. Moreover, increasing R&D expenditure by various companies for drug discovery process is expected to drive the market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and rising awareness about advanced treatments among patients from developing countries such as India and China. In addition, growing medical tourism industry due to cheaper treatment cost compared with developed economies will boost demand fortrypsin solutions in Asia Pacific during the forecast period. Increasing focus on biologics manufacturing by several emerging countries due to regulatory reforms aimed at promoting FDI inflows from other countries are also driving regional market growth (China).
Growth Factors:
- Increasing demand for immobilized trypsin in the pharmaceutical and biotechnology industries for proteomics research and drug discovery.
- Growing demand for immobilized trypsin in the food industry as a digestive enzyme and meat tenderizer.
- Rising use of immobilized trypsin in academic research laboratories for protein purification, characterization, and assay development.
- Increasing application of immobilized trypsin in diagnostic kits and point-of-care testing devices.
Scope Of The Report
Report Attributes
Report Details
Report Title
Immobilized Trypsin Market Research Report
By Type
2 ml, 4 ml, Others
By Application
Academic & Research Institutes, Pharmaceutical Companies
By Companies
Promega, Thermo Scientific, G-Biosciences, SignalChem, Takara, GoldBio, Creative Enzymes, ProteoChem
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
154
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Immobilized Trypsin Market Report Segments:
The global Immobilized Trypsin market is segmented on the basis of:
Types
2 ml, 4 ml, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic & Research Institutes, Pharmaceutical Companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Promega
- Thermo Scientific
- G-Biosciences
- SignalChem
- Takara
- GoldBio
- Creative Enzymes
- ProteoChem
Highlights of The Immobilized Trypsin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2 ml
- 4 ml
- Others
- By Application:
- Academic & Research Institutes
- Pharmaceutical Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Immobilized Trypsin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Immobilized trypsin is a protein that has been chemically immobilized. This means that the protein has been attached to a solid support, such as beads or microspheres, so that it can be easily isolated and analyzed.
Some of the key players operating in the immobilized trypsin market are Promega, Thermo Scientific, G-Biosciences, SignalChem, Takara, GoldBio, Creative Enzymes, ProteoChem.
The immobilized trypsin market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Immobilized Trypsin Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Immobilized Trypsin Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Immobilized Trypsin Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Immobilized Trypsin Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Immobilized Trypsin Market Size & Forecast, 2020-2028 4.5.1 Immobilized Trypsin Market Size and Y-o-Y Growth 4.5.2 Immobilized Trypsin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 2 ml
5.2.2 4 ml
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Academic & Research Institutes
6.2.2 Pharmaceutical Companies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Immobilized Trypsin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Immobilized Trypsin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 2 ml
9.6.2 4 ml
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Academic & Research Institutes
9.10.2 Pharmaceutical Companies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 2 ml
10.6.2 4 ml
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Academic & Research Institutes
10.10.2 Pharmaceutical Companies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 2 ml
11.6.2 4 ml
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Academic & Research Institutes
11.10.2 Pharmaceutical Companies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 2 ml
12.6.2 4 ml
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Academic & Research Institutes
12.10.2 Pharmaceutical Companies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 2 ml
13.6.2 4 ml
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Academic & Research Institutes
13.10.2 Pharmaceutical Companies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Immobilized Trypsin Market: Competitive Dashboard
14.2 Global Immobilized Trypsin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Promega
14.3.2 Thermo Scientific
14.3.3 G-Biosciences
14.3.4 SignalChem
14.3.5 Takara
14.3.6 GoldBio
14.3.7 Creative Enzymes
14.3.8 ProteoChem